Health-economic analysis of alternative bypassing agents in haemophilia complicated by an inhibitor: the FEIBA NovoSeven comparative study (FENOC)

Carlsson KS ;
Astermark J ;
Donfield SM ;
Berntorp E

Lund University Centre for Health Economics, Lund University, Lund, Sweden; Department of Coagulation Disorders, Malm University Hospital, Malm, Sweden; Rho Inc, Chapel Hill, NC, USA

Blood. 2006;108((11):): Abstract No. 457.